Article

Tim and Meghan: Survivor's Journey

Both Tim and Meghan have had firsthand experiences with melanoma, the deadliest form of skin cancer. Walk through their journeys with them as they tell their stories.

Tim: https://vimeo.com/26121616

Meghan: https://vimeo.com/21454600

Related Videos
Image of man with brown hair.
Image of woman with blonde hair.
Image of a woman with brown shoulder-length hair, wearing a khaki colored blazer.
Image of a man wearing a black button-up shirt.
Image of man with black hair.
Image of a man with dark hair and some facial hair.
Image of a man with blond facial hair.
Three women on a Zoom call discussing tracking side effects during breast cancer treatment.
Related Content
Illustration of blood cells.
December 7th 2024

Smoking May Be Linked With Genetic Mutations, Progression Risk in MDS

Darlene Dobkowski, MA
Results from the study also showed the potential association between smoking, disease progression and survival in patients with myelodysplastic syndromes.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Illustration of blood cells.
December 7th 2024

Blincyto With Chemo May Improve Disease-Free Survival in Pediatric B-ALL

Ashling Wahner
Pediatric patients with standard-risk B-ALL demonstrated significantly improved disease-free survival with Blincyto plus chemotherapy versus chemotherapy alone.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of a man receiving radiation therapy for prostate cancer.
December 6th 2024

SBRT May Be Effective in Managing Intermediate-Risk Prostate Cancer

Ashley Chan
Treatment with five-fraction SBRT could be effective versus traditional radiation in certain patients with low- or intermediate-risk prostate cancer.
Image of a man wearing a gray suit.
December 6th 2024

The ABCs of ACDs in Breast Cancer

Debu Tripathy, M.D.
Since 2000, antibody-drug conjugates have been approved by the Food and Drug Administration for various cancer types, such as breast cancer.